KIMBERLY CORONA: Open Payments
NPI 1720503287 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 39 payments from 16 companies in 2025. Trend: 2023 $1,114 · 2024 $832 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Radius Health, Inc. | 7 | $185 |
| Sumitomo Pharma America, Inc. | 12 | $163 |
| Amgen Inc. | 1 | $68 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $58 |
| Dexcom, Inc. | 2 | $47 |
| Astellas Pharma US Inc | 2 | $37 |
| Boston Scientific Corporation | 1 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| MILLICENT US INC | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
Products named: Tymlos, GEMTESA, EVENITY, Dexcom G6 Transmitter, Veozah, Bulkamid - Bulkamid Urethral Bulking Pack 2mL (OUS), FEMLYV, LILETTA.
Industry payments across AL — which companies pay providers there.
